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Fig 2: The enhanced permeability and retention (EPR) effect
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Fig 1: Importance of EGFR in cell signaling. A) Dimerization of
extracellular domains by overexpression or ligand binding results in
phosphorylation of kinase domain and downstream signaling for cell
growth.
Fig. 3 The schematic diagram for preparation and activity of PS5-DoxL.
Results
Fig 4. (A) Particle Size distribution and (B) Zeta Potential graphs of PS5-DoxL
(C) TEM and (D) cryo-TEM images are showing the morphological
characteristics of PS5-DoxL at different magnifications.
Fig 5. In vitro release of 5-Dox from PS5-DoxL and NPS5-DoxL or free Dox
from PS-DoxL at 37 °C, pH 6.5 and 7.4 PBS buffer medium, respectively.
Data represent the mean ± SD (n=3). Statistical significance between PS5-
DoxL 7.4 and PS5-DoxL 6.5 (** p <0 .01 and *** p <0 .001).
Formulation: (PSC5-DOXL)DOPE : CHEMS : CHOL : DSPE-PEG 
2000 : 5-Dox – 4: 2.5 : 2 : 0.5 : 1 molar ratio 
Lipid : Drug ratio – 9 : 1
Fig 6. Stability data of
(A) PS5-DoxL long term
stability stored at 4º C up
to 90 days analyzed in
particle size analyzer, (B)
5-Dox in PS5-DoxL
stored at 4º C up to 90
days analyzed in HPLC,
(C) PS5-DoxL in human
serum up to 72 h, and D.
5-Dox in PS5-DoxL in
human serum up to 72 h
analyzed in HPLC.
Fig 7. In vitro cellular
uptake analysis by
spectrofluorometer
up to 6h in (A) Calu-3
and (B) BT474 cell
lines treated with
PS5-DoxL in pH 7.4
and pH 6.5.Notes:
Data represent the
mean ± SD (n=3).
Statistical
significance between
pH 7.4 and pH 6.5 (*
p <0.05, ** p <0.01,
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Fig. 9 Effect of 5-
Dox and PS5-DoxL









Fig. 10 Apoptosis study on
Calu-3 and BT474 after
treatment with 5-Dox, Free
Dox, and PS5-DoxL for 12 h.
Fig 11. PS5-DoxL inhibits the
phosphorylation of HER2 and
Akt.
Data represented as mean ±
standard deviation *p<0.05,











Fig 13. BT474 3D-
MCTS treated with
PS5-DoxL for 4 h in




In summary, a pH-sensitive liposome formulation containing
peptidomimetic doxorubicin conjugate was developed
targeting HER2 positive lung and breast cancer cells. The PS5-
DoxL formulation could significantly improve selectivity
toward HER2 positive cancer cell lines and increase Dox
accumulation in the tumor for better antitumor efficacy.
